Potential m-calpain substrates during myoblast fusion

Experimental Cell Research

Volumn 246, Issue 2, 1999, Pages 433-442

  Dourdin, N ^a   Balcerzak, D ^a   Brustis, J J ^a   Poussard, S ^a   Cottin, P ^a   Ducastaing, A ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Antisense oligodeoxyribonucleotides; Calpain inhibitors; Desmin; Fibronectin; Fusion; M calpain; Myoblast culture; Talin; Vimentin

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALPAIN; CALPASTATIN; DESMIN; MEMBRANE PROTEIN; TALIN; TYLOXAPOL; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUSION; CONTROLLED STUDY; EMBRYO; IMMUNOBLOTTING; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REGULATORY MECHANISM;

ANIMALIA;

EID: 0033080465     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4325     Document Type: Article

References (36)

1. Sorimachi H., Saido T., Suzuki K. New area of calpain research. FEBS Lett. 343:1994;1-5.
2. Croall D. E., Demartino G. N. Calcium-activated neutral proteases (calpain) system: Structure, function and regulation. Physiol. Rev. 71:1991;813-847.
3. 2+2+. Exp. Cell Res. 162:1986;411-422.
4. Schollmeyer J. E. Possible role of calpain I and calpain II in differentiating muscle. Exp. Cell Res. 163:1986;413-422.
5. Poussard S., Cottin P., Brustis J. J., Talmat S., Elamrani N., Ducastaing A. Quantitative measurement of calpain I and II mRNAs in differentiating rat muscle cells using a competitive polymerase chain reaction method. Biochimie. 75:1993;885-890.
6. Poussard S., Duvert M., Balcerzak D., Ramassamy S., Brustis J. J., Cottin P., Ducastaing A. Evidence for implication of muscle-specific calpain (p94) in myofibrillar integrity. Cell Growth Differ. 7:1996;1461-1469.
7. Balcerzak D., Poussard S., Brustis J. J., Elamrani N., Soriano M., Cottin P., Ducastaing A. An antisense oligodeoxyribonucleotide to m-calpain mRNA inhibits myoblast fusion. J. Cell Sci. 108:1995;2077-2082.
8. Balcerzak D., Cottin P., Poussard S., Cucuron A., Brustis J. J., Ducastaing A. Calpastatin-modulation of m-calpain activity is required for myoblast fusion. Eur. J. Cell Biol. 75:1998;247-253.
9. Brustis J. J., Elamrani N., Balcerzak D., Safwate A., Soriano M., Poussard S., Cottin P., Ducastaing A. Rat myoblast fusion requires exteriorized m-calpain activity. Eur. J. Cell Biol. 64:1994;320-327.
10. Dourdin N., Brustis J. J., Balcerzak D., Elamrani N., Poussard S., Cottin P., Ducastaing A. Myoblast fusion requires fibronectin degradation by exteriorized m-calpain. Exp. Cell Res. 235:1997;385-394.
11. Kwak K. B., Chung S. S., Kim O. M., Kang M. S., Ha D. B., Chung C. H. Increase in the level of m-calpain correlates with the elevated cleavage of filamin during myogenic differentiation of embryonic muscle cells. Biochim. Biophys. Acta. 1175:1993;243-249.
12. Elamrani N., Balcerzak D., Soriano M., Brustis J. J., Cottin P., Poussard S., Ducastaing A. Evidence for fibronectin degradation by calpain II. Biochimie. 75:1993;849-853.
13. Beckerle M. C., Burridge K., De Martino G. N., Croall D. E. Colocalization of calcium-dependent protease II and one of its substrates at sites of cell adhesion. Cell. 51:1987;569-577.
14. 2+. Mol. Cell Biol. 3:1983;1146-1156.
15. Schwartz M. A. Transmembrane signaling by integrins. Trends Cell Biol. 2:1992;304-308.
16. Collier N. C., Wang K. Purification and properties of human platelet P235. A high molecular weight protein substrate of endogenous calcium-activated protease(s). J. Biol. Chem. 257:1982;6937-6943.
17. 2+. J. Biol. Chem. 256:1985;4056-4062.
18. O'Halloran T., Beckerle M. C., Burridge K. Identification of talin as a major cytoplasmic protein implicated in platelet activation. Nature. 312:1985;566-570.
19. 2+. FEBS Lett. 227:1988;209-214.
20. 2+. Biochim. Biophys. Acta. 1223:1994;170-178.
21. Wang K. K. W., Yuen P. W. Calpain inhibition: An overview of its therapeutic potential. Trends Pharmacol. Sci. 15:1994;412-419.
22. Rees D. J., Ades S. E., Singer S. J., Hynes R. O. Sequence and domain structure of talin. Nature. 347:1990;685-689.
23. Van Groningen J. J., Bloemers H. P., Swart G. W. Rat desmin gene structure and expression. Biochim. Biophys. Acta. 1217:1994;107-109.
24. Bussemakers M. J., Verhaegh G. W., Van Bokhoven A., Debruyne F. M., Schalken J. A. Differential expression of vimentin in rat prostatic tumors. Biochem. Biophys. Res. Commun. 182:1992;1254-1259.
25. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
26. Shoeman R. L., Traub P. Assembly of intermediate filaments. BioAssays. 15:1993;605-611.
27. Pruss R. M., Mirsky R., Raff M. C., Thorpe R., Dowding A. J., Anderton B. H. All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody. Cell. 27:1981;419-428.
28. Geisler N., Weber K. Comparison of the proteins of two immunologically distinct intermediate filaments by amino acid sequence analysis: Desmin and vimentin. Proc. Natl. Acad. Sci. USA. 78:1981;4120-4123.
29. 2+. Biol. Chem. Hoppeseyler. 367:1986;1147-1152.
30. Li Z., Paulin D. High level desmin expression depends on a muscle-specific enhancer. J. Biol. Chem. 266:1991;6562-6570.
31. Van de Klundert F. A. J. M., Raats J. M. H., Bloemendal H. Intermediate filaments: Regulation of gene expression and assembly. Eur. J. Biochem. 214:1993;351-366.
32. Li Z., Marchand P., Humbert J., Babinet C., Paulin D. Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development. 117:1993;947-959.
33. Isenberg G., Niggli V. Interaction of cytoskeletal proteins with membrane lipids. Int. Rev. Cytol. 178:1998;73-124.
34. Prives J., Stinitsky M. Increased membrane fluidity precedes fusion of muscle cells. Nature. 268:1977;761-763.
35. Kalderon N., Gilula N. B. Membrane events in myoblasts fusion. J. Cell Biol. 81:1979;411-425.
36. Wakelam M. J. O. The fusion of myoblasts. Biochem. J. 228:1985;1-12.